You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase 1/2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Prostate Cancer, Metastatic Cancer Trial (177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended

Not yet recruiting
  • Cancer
  • +3 more
  • 177Lu-PSMA-I&T - escalating renal absorbed dose
  • 177Lu-PSMA-I&T - recommended phase 2 regime
  • (no location specified)
Jun 14, 2023

Solid Tumor Trial in Birtinya (IBI130)

Not yet recruiting
  • Solid Tumor
  • Birtinya, Queensland, Australia
    Sunshine Coast University
Jun 19, 2023

Duchenne Muscular Dystrophy Trial (NS-050/NCNP-03, Placebo)

Not yet recruiting
  • Duchenne Muscular Dystrophy
  • (no location specified)
Sep 19, 2023

Prostate Cancer Trial (Lutetium Lu 177 JH020002 Injection)

Not yet recruiting
  • Prostate Cancer
  • Lutetium Lu 177 JH020002 Injection
  • (no location specified)
Nov 14, 2023

Corneal Edema, Corneal Endothelial Dysfunction Trial (AURN001)

Not yet recruiting
  • Corneal Edema
  • Corneal Endothelial Dysfunction
  • AURN001
  • (no location specified)
Sep 11, 2023

Non Hodgkin Lymphoma Trial in New York, Clayton, Frankston (IPH6501)

Not yet recruiting
  • Non Hodgkin Lymphoma
  • New York, New York
  • +2 more
Oct 12, 2023

Breast Cancer Metastatic, Pancreatic Cancer, NSCLC, Metastatic Trial in Denver, Grand Rapids (ST316)

Not yet recruiting
  • Breast Cancer Metastatic
  • +7 more
  • Denver, Colorado
  • +1 more
Apr 28, 2023

Duchenne Muscular Dystrophy Trial in Garches (Phase 1, SQY51, Phase 2a, SQY51 (cohort 1), Phase 2a, SQY51 (cohort 2))

Recruiting
  • Duchenne Muscular Dystrophy
  • Phase 1, SQY51
  • +3 more
  • Garches, France
    Hôpital Raymond Poincaré
Mar 7, 2023

Arrhythmogenic Cardiomyopathy, PKP2-ACM, PKP2-ARVC Trial (LX2020)

Not yet recruiting
  • Arrhythmogenic Cardiomyopathy
  • +2 more
  • LX2020
  • (no location specified)
Oct 25, 2023

Neuroendocrine Tumor (NET), Colorectal Cancer (CRC) Trial (CHM-2101 CAR-T cells)

Not yet recruiting
  • Neuroendocrine Tumor (NET)
  • Colorectal Cancer (CRC)
  • CHM-2101 CAR-T cells
  • (no location specified)
Sep 20, 2023

COVID-19, Infectious Disease Trial (JCXH-221, Active Comparator, Placebo)

Not yet recruiting
  • COVID-19
  • Infectious Disease
  • JCXH-221
  • +2 more
  • (no location specified)
Feb 22, 2023

Advanced Solid Tumors Trial in Canada, United States (LCB84, Anti-PD-1 mAb)

Not yet recruiting
  • Advanced Solid Tumors
  • LCB84
  • Anti-PD-1 monoclonal antibody
  • Los Angeles, California
  • +6 more
Jul 4, 2023

Myotonic Dystrophy 1 Trial (ARO-DM1 for Injection, Placebo)

Not yet recruiting
  • Myotonic Dystrophy 1
  • ARO-DM1 for Injection
  • Placebo
  • (no location specified)
Nov 14, 2023

Healthy Trial in Québec (Camlipixant + Gemfibrozil, Dabigatran etexilate + camlipixant)

Not yet recruiting
  • Healthy
  • Camlipixant + Gemfibrozil
  • Dabigatran etexilate + camlipixant
  • Québec, Quebec, Canada
    Syneos Health
Jul 17, 2023

MTAP-null Non-Small-Cell Lung Cancer, MTAP-null Solid Tumors Trial (AMG 193, IDE397)

Not yet recruiting
  • MTAP-null Non-Small-Cell Lung Cancer
  • MTAP-null Solid Tumors
  • (no location specified)
Jul 27, 2023

Down Syndrome Trial in Barcelona (Placebo, AEF0217)

Recruiting
  • Down Syndrome
  • Barcelona, Catalonia, Spain
    Hospital del Mar Medical Research Institute (IMIM),
Feb 27, 2023

FSHD, FSHD1, FSHD2 Trial (AOC 1020, Placebo)

Not yet recruiting
  • FSHD
  • +26 more
  • AOC 1020
  • Placebo
  • (no location specified)
Feb 27, 2023

Healthy Trial in Québec (Camlipixant + Rifampin, Camlipixant + Rabeprazole)

Not yet recruiting
  • Healthy
  • Camlipixant + Rifampin
  • Camlipixant + Rabeprazole
  • Québec, Quebec, Canada
    Syneos Health
Jun 2, 2023

Advanced Solid Tumor (Phase 1), Pancreatic Adenocarcinoma, Malignant Melanoma (Cutaneous) Trial in United States (IMM-1-104)

Recruiting
  • Advanced Solid Tumor (Phase 1)
  • +4 more
  • Duarte, California
  • +4 more
Feb 2, 2023

Type 2 Diabetes (T2DM) Trial in Montréal (ALN-KHK, Placebo)

Recruiting
  • Type 2 Diabetes Mellitus (T2DM)
  • Montréal, Quebec, Canada
    Clinical Trial Site
Mar 7, 2023

Methylmalonic Acidemia (MMA) Trial run by the Selecta Biosciences, Inc. (SEL-302)

Recruiting
  • Methylmalonic Acidemia (MMA)
  • Bethesda, Maryland
    National Human Genome Research Institute, National Institutes of
Mar 9, 2023

Acquired Blepharoptosis Trial (LEV102 1.0%, LEV102 2.0%, Vehicle)

Not yet recruiting
  • Acquired Blepharoptosis
  • LEV102 1.0%
  • +2 more
  • (no location specified)
Feb 6, 2023

Hamstring Injury Trial in Pittsburgh (Losartan, )

Recruiting
  • Hamstring Injury
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Dec 14, 2022

Advanced Cancer Trial in South Brisbane, Bedford Park, Melbourne (AWT020)

Recruiting
  • Advanced Cancer
  • AWT020
  • South Brisbane, Queensland, Australia
  • +2 more
Oct 18, 2023

Stargardt Disease Trial (OCU410ST)

Not yet recruiting
  • Stargardt Disease
  • OCU410ST
  • (no location specified)
Jul 13, 2023